Date | Title | Description |
13.11.2023 | bit.bio announces cell therapy pipeline and expanded Scienti... | Portfolio company bit.bio, the company coding human cells for novel cures, announced its cell therap... |
08.11.2023 | Virica Biotech Receives Grant through Ontario Genomics’ BioC... | Portfolio company Virica Biotech has been selected for the Ontario Genomics’s BioCreate accelerator ... |
25.10.2023 | Cytiva & RoosterBio Collaborate to Address Exosome Manuf... | Portfolio company Rooster Bio is partnering with Cytiva to solve the challenges of cost and quality ... |
12.10.2023 | Daniella Kranjac Mesa Panel Featured in Gen Eng News | Featured in Genetic Engineering & Biotechnology News news the article summarized an exciting pan... |
11.10.2023 | Portfolio Company Vectron Biosolutions and Cytovance Biologi... | Vectron Biosolutions just announced a strategic, international partnership with Cytovance Biologics,... |
27.09.2023 | Portfolio company CellFE Biotech has closed their Series A f... | The round was led by M Ventures , with participation from GreatPoint Ventures and Riverine Ventures,... |
26.09.2023 | Lucid Scientific Secures $7 Million Series A Financing | Portfolio company, Lucid Scientific, announced the closing of a $7M Series A financing led by IAG Ca... |
20.09.2023 | Curi Bio Launches Nautilus™ and Stingray™ Platforms for Adva... | Portfolio company Curi Bio, innovating human stem cell-based platforms for drug discovery, announced... |
03.08.2023 | bit.bio and BlueRock Therapeutics announce collaboration to ... | Tregs play a crucial role in maintaining balance in the body’s immune system and iPSC-derived Treg b... |
02.08.2023 | Alpenglow awarded $1.6M grant to develop AI-enabled smart mi... | Portfolio company Alpenglow Biosciences has been awarded a $1.6M grant by the Andy Hill, Washington’... |
17.07.2023 | Albenglow Biosciences CEO, Nick Reder Featured in Recent Pha... | In this recent Pharma’s Almanac interview, Alpenglow CEO Nicholas Reder, M.D. explains the critical ... |
29.06.2023 | Vernal Biosciences Announces an Additional $20MM in Funding ... | Portfolio company Vernal Biosciences, an innovative mRNA and LNP Contract Development and Manufactur... |
24.04.2023 | Virica Biotch To Expand Domestic Vaccine Manufacturing Capac... | Portfolio company Virica Biotech recently announced a $790k grant from the Ontario Together Fund (“O... |
12.04.2023 | Alpenglow Biosciences and Mayo Clinic enter collaboration ag... | Alpenglow Biosciences collaboration with Mayo Clinic to integrate Alpenglow’s 3D spatial biology pla... |
20.03.2023 | Portfolio Company Vectron Biosolutions Recently Published in... | Vectron's CSO, Jostein Malmo, co-authored a recent article published in Frontiers in Chemical Engine... |
15.03.2023 | Curi Bio Launches MantaReady™ 3D Skeletal Muscle Tissue Medi... | Portfolio company Curi Bio, a leading developer of human stem cell-based platforms for drug discover... |
15.03.2023 | RoosterBio & Repligen Collaborate to Advance Scalable Ex... | Portfolio company Rooster Bio recently announced it has selected Repligen Corporation, a life scienc... |
16.02.2023 | Curi Bio Names Nicholas Geisse, Ph.D., as New Chief Executiv... | Portfolio Company Curi Bio recently announce the new appointment of Nicholas (Nick) Geisse, Ph.D. as... |
10.02.2023 | Portfolio Company Envisagenics Featured in Recent Wuxi AppTe... | Maria Luisa Pineda, PhD, CEO and co-founder of Envisagenics was recently featured in WuXi AppTec’s i... |
10.02.2023 | Portfolio Company BitBio Recently Announced a Partnership wi... | Portfolio company BitBio recently announced a partnership with Automata, a leading life science lab ... |
10.01.2023 | Sartorius Collaborates with RoosterBio to Advance Downstream... | In the latest news, Sartorius AG (Sartorius Stedim Biotech) will continue its strategic collaboratio... |
29.11.2022 | Portfolio Company Envisagenics enters into Multi-Year Collab... | Today portfolio company, Envisagenics, announce a multi-year research collaboration agreement with B... |
14.11.2022 | Daniella Kranjac Recognized in Fierce Pharma's "Fierces... | This prestigious list recognizes the women inspiring, leading, and building diversity in the Life Sc... |
26.10.2022 | Portfolio Co. Vectron Biosolutions Partners with Plant-Based... | Branching outside of traditional biologics, Vectron Biosolutions will support Motif FoodWorks with t... |
24.10.2022 | Portfolio Co. RoosterBio and FUJIFILM Announce Collaboration | FUJIFILM Diosynth Biotechnologies and RoosterBio Announce Collaboration to enable GMP Manufacturing ... |
04.10.2022 | Dynamk Capital makes Inc. Magazine 2022 Founder-Friendly Inv... | Today Inc. Magazine announced their 2022 Founder-Friendly Investors list which included Dynamk Capit... |
13.09.2022 | Daniella Kranjac nominated for "Lifetime Luminary"... | Dynamk Capital is excited to announce that Founding Partner, Daniella Kranjac has been nominated for... |
23.08.2022 | Portfolio Co. CEO Featured n Pharma's Almanac Article | Vectron Biosolutions CEO, Trond Erik Vee Aune, Ph.D. was recently featured in an article discussing ... |
23.08.2022 | Portfolio Co. RoosterBio and AGC Biologics Announce Collabor... | RoosterBio and AGC Biologics Announce Collaboration to Accelerate Manufacturing of Cell and Exosome ... |
28.07.2022 | Dynamk Capital Nominated for the 2022 Prix Galien Awards | We are honored to be nominated for the 2022 Prix Galien “Best Digital Health Solution”, “Incubators,... |
07.06.2022 | Dynamk Capital promotes Jessica Davis to Principal | Jessica Davis, Principal
Dynamk Capital today announced the promotion of Jessica Davis to Principal... |
02.06.2022 | Dynamk Capital Co-Leads $21M Vernal Biosciences round along ... |
COLCHESTER, Vt., June 2, 2022 /PRNewswire/ -- Vernal Biosciences, a technology-leading mRNA manufa... |
27.04.2022 | Bionter AG secures $3 Million in Series Seed Financing Led b... | April 27, 2022, Riehen, Switzerland - Bionter AG, experts in sub-visible particle testing, announced... |
21.04.2022 | Portfolio Company Xcellbio expands Labcorp Collaboration for... | Xcell Biosciences, Inc. (“Xcellbio”), a leading developer of cell and gene therapy technologies has ... |
01.04.2022 | Curi Bio Announces Technology Acquisition & Product Laun... | Portfolio company Curi Bio announced the acquisition of CarTox™ Technology from StemBioSys & Lau... |
03.02.2022 | Portfolio Company Lightspeed Microscopy, Inc. Rebrands to Re... | On February 1, 2022 Lightspeed Microscopy, Inc., announced the company will begin operating under th... |
19.01.2022 | Dynamk Capital Joins World-Class Syndicate of LS Investors P... | Xcell Biosciences, Inc. (“Xcellbio”), a leading developer of innovative technologies and platforms d... |
04.01.2022 | Kayo announces Daniella Kranjac, Dynamk Capital as a Top 22 ... | Kayo Life Sciences announcement: It was another momentous year for science in 2021 and 2022 shows no... |
09.11.2021 | Dynamk Capital Hosts Inaugural Annual General Meeting | In October Dynamk hosted its first Annual General Meeting (AGM) for GPs, LPs, advisors, and partners... |
04.10.2021 | Virica Biotech Raises Series A Financing and Expands Operati... | OTTAWA, Ontario--(BUSINESS WIRE)--Virica Biotech Inc., a leading life science developer of solutions... |
29.09.2021 | Envisagenics Raises Series A Financing to Scale Its AI-power... | Dynamk Portfolio Company, Envisagenics, an Artificial Intelligence-driven biotechnology company focu... |
20.09.2021 | Dynamk announces Gregory Russotti, Ph.D. as Scientific Advis... | Dr. Gregory Russotti has been announced as the newest member of Dynamk Capital’s Scientific Advisory... |
17.06.2021 | Vectron Biosolutions to Boost Protein Production Offering wi... | Trondheim, Norway – June 17, 2021, Vectron Biosolutions, upstream experts providing expression tools... |
15.06.2021 | Lightspeed Microscopy, Inc. raises $4M in Series A Financing... | Seattle, WA – June 15, 2021, Lightspeed Microscopy, Inc., an end-to-end 3D pathology platform, annou... |
26.05.2021 | Dynamk Capital names Jessica Davis, Senior Associate | Jessica Davis, Senior Associate
Dynamk Capital announced today the addition of Jessica Davis, Senio... |
27.04.2021 | Dynamk Capital Announces Final Closing of its Life Science I... | New York, NY – April 27, 2021 – Dynamk Capital LLC, a venture fund providing early stage and growth ... |
18.03.2021 | Curi Bio Raises $6M Series A Financing Round for iPSC-derive... | Seattle, WA – March18, 2021 – Curi Bio Inc., a leading developer of human stem cell-based platforms ... |
05.01.2021 | Dynamk Capital Promotes Sebastien Latapie to Principal | Sebastien Latapie
Dynamk Capital today announced the promotion of Sebastien Latapie to Principal. S... |
11.10.2020 | Dynamk Capital talks the Future of Healthcare with Pharma’s ... | - |
01.10.2020 | Dynamk featured in Pharma’s Almanac article on disruptive Or... | Read more here. |
01.10.2020 | Lucid Scientific Secures $3 Million in Series Seed Financing... | Maker of real-time cell analysis systems plans capacity expansion in production, customer success, a... |
13.07.2020 | Dynamk Launches Industry Insights Newsletter: Quarterly Tren... | Proud to launch the first installment of our Life Science Industrials Insights newsletter covering Q... |
07.04.2020 | Dr. Gustavo Mahler Now a General Partner at Dynamk Capital | Dr. Gustavo Mahler
NEW YORK, New York, April 7, 2020 /PRNewswire/ — Dynamk Capital, a growth equity... |
16.01.2020 | CellFE Raises $3.6 Million in Series Seed Round Co-Led by Dy... | San Carlos, CA – January 16, 2020 – CellFE, Inc., an innovative startup developing a microfluidics b... |
10.01.2020 | Dynamk Capital participates in Life Science Investor Panel d... | San Francisco, CA – January 14, 2020 – RESI Redefining Early Stage Investments Conference 2020 Life ... |
05.11.2019 | Dynamk Capital sponsors Life Sciences Washington VIP Forum | Seattle, WA – November 20-21, 2019 – Join Dr. Gustavo Mahler, Daniella Kranjac and Sebastien Latapie... |
10.10.2019 | FloDesign Sonics Acquired by MilliporeSigma | Dynamk Capital is pleased to announce that FloDesign has closed a merger transaction with MilliporeS... |
06.08.2019 | RoosterBio Raises $15 Million in Series B Round Led by Dynam... | FREDERICK, MD and NEW YORK, NY – August 6, 2019 – RoosterBio Inc, disrupting the market by radically... |
29.05.2019 | Dr. Gustavo Mahler joins Dynamk Capital as Venture Partner | Dr Gustavo Mahler
Dr. Gustavo Mahler joins Dynamk Capital as a Venture Partner after leaving his 10... |
27.05.2019 | Dynamk Capital names Sebastien Latapie, Senior Venture Assoc... | Sebastien Latapie
Dynamk Capital announced today the addition of Sebastien Latapie, Senior Venture ... |
07.01.2019 | Dynamk Capital Announces New Partner, Reinhard Vogt | Dynamk Capital, a venture fund providing early stage and growth capital to innovative Life Science c... |
11.11.2018 | Dynamk participates in the Global Family Office Investment S... | Daniella Kranjac, Founding Partner of Dynamk Capital, talks Life Science and Biotech trends at the G... |
19.06.2018 | Dynamk Announces Advisory Team | Kevin Bailey, PhD
Barry Buckland, PhD
Anthony Maddaluna
Gustavo Mahler, PhD
Dynamk Capital, a ve... |
- |
CellFE Secures $4.8M Seed Round Funding Co-led by Dynamk C... | News provided by
Mar 31, 2020, 06:00 ET
Share this article
SAN CARLOS, Calif., March 31, 2020 /PR... |